跳至主要内容
临床试验/CTRI/2020/12/030052
CTRI/2020/12/030052尚未招募不适用

COVID19 SEROLOGY IN HEALTH CARE WORKERS AT TERTIARY CARE CENTRE

SRM1 个研究点 分布在 1 个国家目标入组 120 人开始时间: 2021年1月20日最近更新:

试验速览

阶段
不适用
状态
尚未招募
发起方
SRM
入组人数
120
试验地点
1
主要终点
To evaluate the sero-prevalence of IgG Sar-CoV2 in Health care workers who are exposed to COVID-19 patients, in SRM MCH&RC, Tertiary care Hospital.

研究概览

简要总结

For this study, we would be recruiting the Cases and Controls after scrutinizing through the questionnaire for their eligibility. 

The enrolled subjects shall be given Pretest and Post test counceling.

Informed Consent shall be taken (Using bilingual english and tamil consent form).

Demographic details shall be collected.

Under aseptic precautions 2 ml of venous blood shall be collected in plain vacutainer.

The serum will be separated andprocessed for detection of IgG COVID 19 antibodies

Statistical analysis will be done. Results  shall be interpreted

研究设计

研究类型
Observational

入排标准

年龄范围
18.00 Year(s) 至 60.00 Year(s)(—)
性别
All

入选标准

  • All Health care workers working in SRM MCH & RC, Potheri In Covid 19 – ICU Wards and OP clinic In non-COVID 19 ICU Wards and OP Clinics Without daily patient contact Healthy individuals as Controls.

排除标准

  • Individuals with typical symptoms of COVID 19 Individuals not giving Consent for the study.

结局指标

主要结局

To evaluate the sero-prevalence of IgG Sar-CoV2 in Health care workers who are exposed to COVID-19 patients, in SRM MCH&RC, Tertiary care Hospital.

时间窗: 4 to 8weeks

次要结局

  • Identifying these individuals at earliest allows close follow-up for screening them to assess and prevent end organ damage.(To reassure our HCWs that they are not infected and to adhere, the same precautionary measures that they were following.)

研究者

发起方
SRM
申办方类型
Research institution

研究点 (1)

Loading locations...

相似试验